Litigation Details for Neurocrine Biosciences, Inc. v. Lupin Limited (D. Del. 2021)
✉ Email this page to a colleague
Neurocrine Biosciences, Inc. v. Lupin Limited (D. Del. 2021)
| Docket | ⤷ Try a Trial | Date Filed | 2021-07-16 |
| Court | District Court, D. Delaware | Date Terminated | |
| Cause | 35:271 Patent Infringement | Assigned To | Maryellen Noreika |
| Jury Demand | None | Referred To | |
| Parties | CADILA HEALTHCARE LIMITED | ||
| Patents | 10,065,952; 8,039,627; 8,357,697 | ||
| Attorneys | John C. Phillips , Jr. | ||
| Firms | Bayard, P.A. | ||
| Link to Docket | External link to docket | ||
Small Molecule Drugs cited in Neurocrine Biosciences, Inc. v. Lupin Limited
The small molecule drug covered by the patents cited in this case is ⤷ Try a Trial .
Details for Neurocrine Biosciences, Inc. v. Lupin Limited (D. Del. 2021)
| Date Filed | Document No. | Description | Snippet | Link To Document |
|---|---|---|---|---|
| 2021-07-16 | 1 | Complaint | “the ’697 patent”), 10,065,952 (“the ’952 patent”), 10,844,058 (“the ’058 patent”), 10,851,103 (“the …civil action for patent infringement of U.S. Patent Nos. 8,039,627 (“the ’627 patent”), 8,357,697 (“the…the ’103 patent”), 10,851,104 (“the ’104 patent”), 10,857,137 (“the ’137 patent”), 10,857,148 (“the ’148…148 patent”), 10,874,648 (“the ’648 patent”), 10,906,902 (“the ’902 patent”), 10,906,903 (“the ’903 patent… patent”), 10,912,771 (“the ’771 patent”), 10,919,892 (“the ’892 patent”), 10,940,141 (“the ’141 patent | External link to document |
| 2023-01-11 | 122 | Notice of Service | Initial Infringement Contentions for U.S. Patent Nos. 8,039,627, 8,357,697 and 11,311,532 (Crystal Pharmaceutical… 16 July 2021 1:21-cv-01042 835 Patent - Abbreviated New Drug Application(ANDA) None | External link to document |
| 2023-03-10 | 152 | Notice of Service | Initial Non-Infringement Contentions for U.S. Patent Nos. 10,065,952; 10,844,058; 10,851,103; and 10,851,104… 16 July 2021 1:21-cv-01042 835 Patent - Abbreviated New Drug Application(ANDA) None | External link to document |
| 2023-06-30 | 235 | Notice of Service | Plaintiff's Infringement Contentions for U.S. Patent Nos. 8,039,627 and 8,357,697 (Zydus Pharmaceuticals (USA… 16 July 2021 1:21-cv-01042 835 Patent - Abbreviated New Drug Application(ANDA) None | External link to document |
| 2023-07-07 | 236 | Notice of Service | Final Noninfringement Contentions for U.S. Patent Nos. 8,039,627 and 8,357,697 and Zydus Pharmaceuticals …Limiteds Final Invalidity Contentions for U.S. Patent Nos. 8,039,627 and 8,357,697 filed by Zydus Lifesciences… 16 July 2021 1:21-cv-01042 835 Patent - Abbreviated New Drug Application(ANDA) None | External link to document |
| >Date Filed | >Document No. | >Description | >Snippet | >Link To Document |
